Vol. 19/No. 4 | OncologyLive

Triplet Therapy May Be on the Horizon for BRAF-Mutant Melanoma

February 21, 2018

The past decade of drug discovery has brought a dramatic expansion in the number of new therapies to treat patients with advanced or metastatic melanoma in 2 modalities: checkpoint blockade immunotherapies and molecularly targeted drugs.

Decision Support Is Lacking in Flood of New Data

February 14, 2018

Decision support is only lightly touched upon in the academic oncology papers that are published almost daily suggesting a potential change in paradigms for management in a particular clinical setting.